Amicus Therapeutics Inc (FOLD)
10.52
+0.18
(+1.79%)
USD |
NASDAQ |
May 07, 11:32
Amicus Therapeutics Market Cap: 3.109B for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 3.054B |
| May 03, 2024 | 3.072B |
| May 02, 2024 | 3.081B |
| May 01, 2024 | 3.081B |
| April 30, 2024 | 2.951B |
| April 29, 2024 | 3.028B |
| April 26, 2024 | 3.037B |
| April 25, 2024 | 3.004B |
| April 24, 2024 | 3.113B |
| April 23, 2024 | 3.164B |
| April 22, 2024 | 3.196B |
| April 19, 2024 | 3.134B |
| April 18, 2024 | 3.051B |
| April 17, 2024 | 3.116B |
| April 16, 2024 | 3.119B |
| April 15, 2024 | 3.149B |
| April 12, 2024 | 3.155B |
| April 11, 2024 | 3.314B |
| April 10, 2024 | 3.329B |
| April 09, 2024 | 3.471B |
| April 08, 2024 | 3.426B |
| April 05, 2024 | 3.462B |
| April 04, 2024 | 3.385B |
| April 03, 2024 | 3.359B |
| April 02, 2024 | 3.359B |
| Date | Value |
|---|---|
| April 01, 2024 | 3.471B |
| March 28, 2024 | 3.480B |
| March 27, 2024 | 3.503B |
| March 26, 2024 | 3.376B |
| March 25, 2024 | 3.409B |
| March 22, 2024 | 3.406B |
| March 21, 2024 | 3.453B |
| March 20, 2024 | 3.545B |
| March 19, 2024 | 3.497B |
| March 18, 2024 | 3.421B |
| March 15, 2024 | 3.391B |
| March 14, 2024 | 3.409B |
| March 13, 2024 | 3.488B |
| March 12, 2024 | 3.483B |
| March 11, 2024 | 3.583B |
| March 08, 2024 | 3.633B |
| March 07, 2024 | 3.630B |
| March 06, 2024 | 3.722B |
| March 05, 2024 | 3.943B |
| March 04, 2024 | 3.976B |
| March 01, 2024 | 3.926B |
| February 29, 2024 | 3.787B |
| February 28, 2024 | 3.825B |
| February 27, 2024 | 4.091B |
| February 26, 2024 | 4.070B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.706B
Minimum
Mar 12 2020
6.486B
Maximum
Dec 22 2020
3.208B
Average
3.126B
Median
Market Cap Benchmarks
| TG Therapeutics Inc | 2.616B |
| Geron Corp | 2.278B |
| Vanda Pharmaceuticals Inc | 319.91M |
| Fate Therapeutics Inc | 391.00M |
| Editas Medicine Inc | 466.34M |
Market Cap Related Metrics
| PS Ratio | 7.779 |
| Price to Book Value | 19.41 |
| Price | 10.52 |
| Earnings Yield | -4.85% |